All BioTelemetry articles

  • Philips
    News Brief

    Philips unit settles DOJ false claims case for $14.7M


    Wireless medical technology company BioTelemetry and its subsidiary LifeWatch Services agreed to pay more than $14.7 million as part of a settlement with the Department of Justice regarding alleged false claims submitted to federal healthcare programs.

  • DOJ building

    BioTelemetry to pay $44.8M over India testing false claims


    BioTelemetry and CardioNet agreed to pay more than $44.8 million to settle allegations they violated U.S. federal health laws by improperly billing Medicare and other federal programs for heart monitoring and cardiac test analyses performed by a company in India.